Iovance Biotherapeutics (IOVA) Other Non Operating Income (2010 - 2014)
Iovance Biotherapeutics (IOVA) posted quarterly Other Non Operating Income of $1810.0 for Q4 2014, up 196.24% year-over-year from $611.0 in Q4 2013, and up 196.24% quarter-over-quarter from $611.0 in Q4 2013.
Iovance Biotherapeutics (IOVA) Other Non Operating Income (2010 - 2014) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Other Non Operating Income for 5 consecutive years, with $1810.0 the latest figure, recorded in Q4 2014.
- In Q4 2014, Other Non Operating Income rose 196.24% year-over-year to $1810.0; the TTM figure through Dec 2014 stood at $6.1 million (down 17.65% YoY), while the FY2025 annual figure was $1.7 million, changed N/A from the prior year.
- Other Non Operating Income improved to $1810.0 in Q4 2014 per IOVA's latest filing, from $611.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $3.8 million in Q4 2012 and bottomed at -$4.2 million in Q4 2011.
- Historically, Other Non Operating Income has averaged $57140.6 across 5 years, with a median of $9214.0 in 2010.
- On a YoY basis, Other Non Operating Income climbed as much as 52973.02% in 2012 and fell as far as 2906.21% in 2012.
- Iovance Biotherapeutics' Other Non Operating Income stood at $317503.0 in 2010, then sank by 1412.38% to -$4.2 million in 2011, then soared by 192.38% to $3.8 million in 2012, then plunged by 99.98% to $611.0 in 2013, then surged by 196.24% to $1810.0 in 2014.
- Business Quant data shows IOVA's Other Non Operating Income at $1810.0 in Q4 2014, $611.0 in Q4 2013, and $3.8 million in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 1,810.00 |
| Dec 31, 2013 | 611.00 |
| Dec 31, 2012 | 3.85 Mn |
| Sep 30, 2012 | 2.29 Mn |
| Jun 30, 2012 | 1.32 Mn |
| Mar 31, 2012 | -2.64 Mn |
| Dec 31, 2011 | -4.17 Mn |
| Sep 30, 2011 | -4,337.00 |
| Jun 30, 2011 | -398,556.00 |
| Mar 31, 2011 | 93,954.00 |
| Dec 31, 2010 | 317,503.00 |
| Sep 30, 2010 | 16,618.00 |